Ftse Mib
36.719,35
0,00%
DAX
21.505,70
0,47%
S&P 500
6.037,88
0,72%
NASDAQ
19.654,02
1,35%
Bitcoin
97.780,54
-0,08%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Eterna Therapeutics Inc (ERNA) Eterna Therapeutics Inc (ERNA) Notizie

Eterna Therapeutics Inc

ERNA
0,3455
-0,0161 (-4,45%)
05 Feb 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
28/1/202523:31EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by..
28/1/202514:30GLOBEEterna Therapeutics Announces Expansion of Scientific..
14/1/202523:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/1/202523:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
14/1/202514:30GLOBEEterna Therapeutics Announces Positive Preclinical Study..
10/1/202522:15EDGAR2Form 8-K - Current report
09/1/202513:30GLOBEEterna Therapeutics Announces Appointment of Dr. Elena..
03/12/202414:30GLOBEEterna Therapeutics Launches Research to Evaluate its Lead..
25/11/202414:30GLOBEEterna Therapeutics Announces Up to $1 Million Stock..
18/11/202422:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/202414:30GLOBEEterna Therapeutics Regains Compliance with NASDAQ for..
12/11/202423:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/11/202422:30EDGAR2Form S-1 - General form for registration of securities under..
05/11/202418:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202413:30GLOBEEterna Therapeutics Completes Strategic Financial..
29/10/202421:30EDGAR2Form 8-K - Current report
17/10/202414:00GLOBEEterna Therapeutics and Factor Bioscience Announce Exclusive..
27/9/202422:47EDGAR2Form PRE 14A - Other preliminary proxy statements
27/9/202422:15EDGAR2Form 8-K - Current report
25/9/202422:36EDGAR2Form 8-K - Current report
23/9/202422:30EDGAR2Form 8-K - Current report
19/8/202423:00EDGAR2Form 8-K - Current report
13/8/202422:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202423:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202414:00GLOBEEterna Therapeutics to Present at the ASGCT 27th Annual..
08/5/202415:31GLOBEEterna Therapeutics Announces Appointment of Mahendra Rao,..
07/5/202414:00GLOBEEterna Therapeutics to Present at the ASGCT 27th Annual..
20/2/202414:30GLOBEEterna Therapeutics Announces the Appointment of Peter..
16/2/202423:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
16/2/202413:30EDGAR2Form 8-K - Current report
Apertura: 0,3639 Min: 0,345001 Max: 0,3681
Chiusura: 0,3616

La tua Cronologia

NASDAQ
ERNA
Eterna Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci